The Spanish Society of Pediatric Infectious Diseases Guidelines for the diagnosis and treatment of congenital toxoplasmosis;Guía de la Sociedad Española de Infectología Pediátrica para el diagnóstico y tratamiento de la toxoplasmosis congénita

Anales de Pediatria

Volumn 79, Issue 2, 2013, Pages

  Baquero Artigao, F ^a   Del Castillo Martin F ^a   Fuentes Corripio, I ^b   Gonce Mellgren A ^c   Fortuny Guasch, C ^d   De La Calle Fernandez Miranda M ^e   Gonzalez Tome M I ^f   Couceiro Gianzo, J A ^g   Neth, O ^h   Ramos Amador, J T ⁱ  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g Servicio de Pediatria   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Chorioretinitis; Congenital toxoplasmosis; Diagnosis; Newborn; Pregnancy; Pyrimethamine sulfadiazine; Serology; Spiramycin; Treatment

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; SULFADIAZINE;

AMNION FLUID ANALYSIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD EXAMINATION; CEREBROSPINAL FLUID EXAMINATION; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; LEARNING DISORDER; PARASITE TRANSMISSION; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; SEROCONVERSION; THIRD TRIMESTER PREGNANCY; VISUAL IMPAIRMENT;

CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; CORIORRETINITIS; DIAGNOSIS; DIAGNÓSTICO; EMBARAZO; ESPIRAMICINA; NEONATO; NEWBORN; PIRIMETAMINA-SULFADIAZINA; PREGNANCY; PYRIMETHAMINE-SULFADIAZINE; SEROLOGÍA; SEROLOGY; SPIRAMYCIN; TOXOPLASMOSIS CONGÉNITA; TRATAMIENTO; TREATMENT;

ALGORITHMS; FEMALE; FETAL DISEASES; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; SEROLOGIC TESTS; TOXOPLASMOSIS, CONGENITAL;

EID: 84880758113     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2012.12.001     Document Type: Article

References (80)

1. F. De Ory Manchón Encuestas seroepidemiológicas en enfermedades no inmunoprevenibles y su interés en salud pública Rev Esp Salud Pública 83 2009 645 657
2. I. Fuentes Desarrollo de técnicas de ADN para el diagnóstico y caracterización de Toxoplasma gondii. Aplicación a estudios epidemiológicos 2005 Servicio de Publicaciones Universidad Complutense Madrid
3. F. Del Castillo Martín Toxoplasmosis congénita. Una enfermedad con demasiados interrogantes An Pediatr (Barc) 61 2004 115 117
4. B. Magi, and L. Migliorini Western blotting for the diagnosis of congenital toxoplasmosis New Microbiol 34 2011 93 95
5. J.G. Montoya, and O. Liesenfeld Toxoplasmosis Lancet 363 2004 1965 1976
6. E. Rorman, C.S. Zamir, I. Rilkis, and H. Ben-David Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection Reprod Toxicol 21 2006 458 472
7. J.S. Remington, P. Thulliez, and J.G. Montoya Recent developments for diagnosis of toxoplasmosis J Clin Microbiol 42 2004 941 945
8. R. Abdul-Ghani Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation Parasitol Res 108 2011 505 512
9. Y. Sterkers, J. Ribot, S. Albaba, E. Issert, P. Bastien, and F. Pratlong Diagnosis of congenital toxoplasmosis by polymerase chain reaction on neonatal peripheral blood Diagn Microbiol Infect Dis 71 2011 174 176
10. L. Thalib, L. Gras, S. Romand, A. Prusa, M.H. Bessieres, and E. Petersen Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid BJOG 112 2005 567 574
11. M. Wallon, J. Franck, P. Thulliez, C. Huissoud, F. Peyron, and P. Garcia-Meric Accuracy of Real-Time polymerase chain reaction for Toxoplasma gondii in amniotic fluid Obstet Gynecol 115 2010 727 733
12. Y. Sterkers, E. Varlet-Marie, S. Cassaing, M.P. Brenier-Pinchart, S. Brun, and F. Dalle Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens J Clin Microbiol 48 2010 3216 3222
13. J.G. Montoya, and J.S. Remington Management of Toxoplasma gondii infection during pregnancy Clin Infect Dis 47 2008 554 566
14. Y. Sterkers, F. Pratlong, S. Albaba, J. Loubersac, M.C. Picot, and V. Pretet A novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at maternal infection J Clin Microbiol 50 2012 3944 3951
15. S. Romand, M. Chosson, J. Franck, M. Wallon, F. Kieffer, and K. Kaiser Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii Am J Obstet Gynecol 190 2004 797 802
16. F. Robert-Gangneux, P. Dupretz, C. Yvenou, D. Quinio, P. Poulain, and C. Guiguen Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis Pediatr Infect Dis J 29 2010 33 38
17. J. Couvreur Infections in neonates and infants D.H.M. Joynson, T.G. Wreghitt, Toxoplasmosis. A comprehensive clinical guide 2001 Cambridge University Press 254 276
18. I. Fuentes, M. Rodriguez, C.J. Domingo, F. del Castillo, T. Juncosa, and J. Alvar Urine sample used for congenital toxoplasmosis diagnosis by PCR J Clin Microbiol 34 1996 2368 2371
19. J.S. Remington, R. McLeod, C.B. Wilson, and G. Desmonts Toxoplasmosis J.S. Remington, J. Klein, C.B. Wilson, V. Nizet, Y.A. Maldonado, Infectious diseases of the fetus and newborn infant 7th ed. 2011 Elsevier-Saunders Philadelphia 918 1041
20. Petersen E, Salmi R, Chêne G, Thiebaut R, Gilbert R. Protozoal diseases: toxoplasmosis. En: International Encyclopedia of Public Health. 1st ed. 2008;5:382-94.
21. Documentos de Consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO). Toxoplasmosis. Documento n. 151. 2002. Coordinadora: González González, NL. [consultado 26 nov 2012]. Disponible en: www.sego.es
22. O. Liesenfeld, J.G. Montoya, S. Kinney, C. Press, and J.S. Remington Confirmatory serological testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers Am J Obstet Gynecol 184 2001 140 145
23. E. Petersen, M.V. Borobio, E. Guy, O. Liesenfeld, V. Meroni, and A. Naessens European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index J Clin Microbiol 43 2005 1570 1574
24. G. Desmonts, and J. Couvreur Congenital toxoplasmosis: a prospective study of 378 pregnancies N Eng J Med 290 1974 1110 1116
25. R. Thiébaut, S. Leproust, G. Chene, R. Gilbert SYROCOT (Systematic Review on Congenital Toxoplasmosis) study Group Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data Lancet 369 2007 115 122
26. Y. Carlier, C. Truyens, P. Deloron, and F. Peyron Congenital parasitic infections: a review Acta Trop 121 2012 55 70
27. G. Malinger, H. Werner, J.C. Rodriguez Leonel, M. Rebolledo, M. Duque, and S. Mizyrycki Prenatal brain imaging in congenital toxoplasmosis Prenat Diagn 31 2011 881 886
28. L. Mandelbrot Prevention de la transmission mère-enfant de la toxoplasmose: perspectives Gynecol Obstet Fertil 40 2012 591 598
29. C. Garel Antenatal cerebral pathologies of infectious origin: toxoplasmosis C. Garel, MRI of the fetal brain. Normal development and cerebral pathologies 2004 Springer-Verlag Berlin, Heidelberg, New York
30. A. Berrebi, M. Bardou, M.H. Bessieres, D. Nowakowska, R. Castagno, and M. Rolland Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases Eur J Obstet Gynecol Reprod Biol 135 2007 53 57
31. D. Dunn, M. Wallon, F. Peyron, E. Petersen, C. Peckham, and R. Gilbert Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling Lancet 353 1999 1829 1833
32. M. Wallon, P. Gaucherand, M. Al Kurdi, and F. Peyron Infection toxoplasmique de debut de grossesse: conséquences et conduite à tenir J Gynecol Obstet Biol Reprod (Paris) 31 2002 478 484
33. R. Thiébaut, V. Leroy, A. Alioum, C. Binquet, G. Poizat, and Salmi Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis Eur J Obstet Gynecol Reprod Biol 124 2006 3 9
34. R. Gilbert, and L. Gras European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii BJOG 110 2003 112 120
35. M. Cortina-Borja, H.K. Tan, M. Wallon, M. Paul, A. Prusa, and W. Buffolano Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study Plos Med 12 2010 e1000351
36. K. Freeman, H.K. Tan, A. Prusa, E. Petersen, W. Buffolano, and G. Malm Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study Pediatrics 2008 1215 1222
37. C. Binquet, M. Wallon, P. Metral, M. Gadreau, C. Quentin, and F. Peyron Toxoplasmosis seroconversion in pregnant women. The differing attitudes in France Presse Med 10 2004 775 779
38. F. Derouin, E. Jacqz-Aigrain, P. Thulliez, J. Couvreur, and C. Leport Cotrimoxazole for prenatal treatment of congenital toxoplasmosis? Parasitol Today 16 2000 254 256
39. F. Robert, K. Boyer, and R. McLeod Toxoplasmosis A.A. Gershon, P.J. Hotez, S.L. Katz, Krugman's Infectious diseases of children 11th ed 2004 Mosby Philadelphia 697 730
40. F. Del Castillo Martín Diagnóstico y tratamiento de la toxoplasmosis congénita An Pediatr Contin 3 2005 65 72
41. J. McAuley, K.M. Boyer, D. Patel, M.M. Mets, C. Swisher, and N. Roizen Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial Clin Infect Dis 18 1994 38 72
42. A.M. Benéitez, F. del Castillo, S. Salas, M.A. San José, R. Martinez Zapico, and C. Ladrón de Guevara Valor de los anticuerpos IgM antitoxoplasma durante la gestación Clin Invest Gin Obst 25 1998 107 110
43. K.M. Boyer, J.F. Marcinak, and R.L. McLeod Toxoplasma gondii (toxoplasmosis) S.S. Long, L.K. Pickering, C.G. Prober, Principles and practice of pediatric infectious diseases 3th ed. 2008 Churchill Livingstone New York 1267 1290
44. J.B. McAuley, K.M. Boyer, J.S. Remington, and R.L. McLeod Toxoplasmosis R.D. Feigin, J.D. Cherry, G.J. Demmler-Harrison, S.L. Kaplan, Texbook of pediatric infectious diseases 6th ed. 2009 Saunders Philadelphia 2954
45. M. Wallon, L. Kodjikian, C. Binquet, J. Garweg, J. Fleury, and C. Quantin Long-term ocular prognosis in 327 children with congenital toxoplasmosis Pediatr 113 2004 1567 1572
46. A.P. Brezin, R. Thilliez, J. Couvreur, R. Nobré, R. Mcleod, and M.B. Mets Ophthalmic outcome after pre- and postnatal treatment of congenital toxoplasmosis Am J Ophthal 135 2003 779 784
47. R. McLeod, K.M. Boyer, T. Karrison, K. Kasza, C. Swisher, and N. Roizen Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based Congenital Toxoplasmosis Study Clin Infec Dis 42 2006 1383
48. N. Roizen, R. McLeod, T. Karrison, M. Mets, A.G. Noble, and K. Boyer Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies Pediatrics 118 2006 379 390
49. B. Faucher, P. Garcia-Meric, J. Franck, P. Minodier, P. Francois, and S. Gonnet Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children J Infect 64 2011 104 109
50. American Academy of Pediatrics. Toxoplasma gondii infections (Toxoplasmosis). En: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editores. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009. p. 667-72.
51. P. Garcia-Meric, J. Franck, H. Dumon, and R. Piarroux Prise en charge de la toxoplasmose congenital en France: données acualles (Management of congenital toxoplasmosis in France: current data) La Prense Medicale 39 2010 530 538
52. D. Remmer Schmidt, B. Hogh, O. Andersen, S.H. Hansen, K. Dalhoff, and E. Petersen Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine Eur J Pediatr 165 2006 19 25
53. D. Villena, B. Aubert, D. Leroux, D. Dupouy, C. Talmud, and C. Chemla Pyrimetamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997 Scand J Infect Dis 30 1998 295 300
54. C.B. Wilson, J.S. Remington, S. Stagno, and D.W. Reynolds Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection Pediatrics 66 1980 767 774
55. L. Phan, K. Kasza, J. Jalbrzikowski, A.G. Noble, P. Latkany, and A. Kuo Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life Am J Ophtalmol 146 2008 375 384
56. L. Phan, K. Kasza, J. Jalbrzikowski, A.G. Noble, P. Latkany, and A. Kuo Longitudinal study of new eye lesions in treated congenital toxoplasmosis Ophtalmology 115 2008 553 559
57. M. Lebech, D.H.M. Joynson, H.M. Seitz, P. Thulliez, R.E. Gilbert, and G.N. Dutton Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring Eur J Clin Microbiol Infect Dis 15 1996 799 805
58. V. Rilling, K. Dietz, D. Krezal, F. Knotek, and G. Enders Evaluation of commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis Eur J Clin Microbiol Infect Dis 22 2003 174 180
59. M. Lebech, N.C. Christensen, J. Hertel, H.E. Nielsen, B. Peitersen, and C. Rechnitzer Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group Lancet 353 1999 1834 1837
60. H.K. Tan, E. Petersen, L.N. Moller, P. Phillips, E.C. Neto, and R.E. Gilbert Recovery of anti-Toxoplasma gondii immunoglobulin M in stored guthrie card blood spots J Clin Microbiol 47 2009 2626 2628
61. E. Petersen, and R.B. Eaton Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples Acta Paediatr Suppl 88 1999 36 39
62. E. Chapey, M. Wallon, G. Debize, M. Rabilloud, and F. Peyron Diagnosis of congenital toxoplasmosis using a whole-blood gamma interferon release assay J Clin Microbiol 48 2010 41 45
63. J.G. Montoya Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis J Infect Dis 185 Suppl 2002 S73 S82
64. M. Paul, E. Petersen, Z.S. Pawlowski, and J. Szczapa Neonatal screening for congenital toxoplasmosis in the Poznán region of Poland by analysis of Toxoplasma gondii-especific IgM antibodies eluted from filter paper blood spots Pediatr Infect Dis J 19 2000 30 36
65. L. Ciardelli, V. Meroni, M.A. Avanzini, L. Bollani, C. Tinelli, and F. Garofoli Early and accurate diagnosis of congenital toxoplasmosis Pediatr Infect Dis 27 2008 125 129
66. G.N. Dutton Ocular infection D.H.M. Joyson, T.G. Wreghitt, Toxoplasmosis 2001 Cambrige University Press 277 295
67. G.N. Holland Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management Am J Ophthalmol 137 2004 1 17
68. E. Delair, D. Monnet, S. Grabar, J. Dupouy-Camet, H. Yera, and A.P. Brézin Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis Am J Ophthalmol 146 2008 851 855
69. M.R. Stanford, H.K. Tan, and R.E. Gilbert Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey Br J Ophthalmol 90 2006 1464 1467
70. J.G. Garweg, J.D.F. De Groot-Mijnes, and J.G. Montoya Diagnostic approach to ocular toxoplasmosis Ocul Immunol Inflamm 19 2011 255 261
71. H. Talabani, M. Asscraf, H. Yera, E. Delair, T. Ancelle, and P. Thulliez Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis J Clin Microbiol 47 2009 2131 2135
72. R. Gangneux, P. Binisti, D. Antonetti, A. Brezin, H. Yera, and J. Dupouy-Camet Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis Eur J Clin Microbiol Infect Dis 23 2004 34 38
73. A.G. Commodaro, R.N. Belfort, L.V. Rizzo, C. Muccioli, C. Silveira, and M.N. Burnier Ocular toxoplasmosis-an update and review of the literature Mem Inst Oswaldo Cruz 104 2009 345 350
74. M. Soheilian, M.M. Sadoughi, M. Ghajarnia, M.H. Dehghan, S. Yazdani, and H. Behboudi Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis Ophtalmology 112 2005 1876 1882
75. C. Silveira, R. Belfort Jr., C. Muccioli, G.N. Holland, C.G. Victora, and B.L. Horta The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis Am J Ophthalmol 134 2002 41 46
76. Guerina NG, Lee J, Lynfield R. Congenital toxoplasmosis: treatment, outcome and prevention. Up to date 2012. [consultado 26 nov 2012]. Disponible en: www.uptodate.com
77. B. Iaccheri, T. Fiore, T. Papadaki, S. Androudi, S. Janjua, and I. Bhaila Adverse drug reactions to treatments for ocular toxoplasmosis: a restrospective chart review Clin Ther 30 2008 2069 2074
78. A. Berrébi, C. Assouline, M.H. Bessiéres, M. Lathiére, S. Cassaing, and V. Minville Long term outcome of children with congenital toxoplasmosis Am J Obstrect Gynecol 203 2010 552 e1-6
79. M. Wallon, G. Cozon, R. Ecochard, P. Lewin, and F. Peyron Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children Eur J Pediatr 160 2001 534 540
80. M.A. Kish Guide to development of practice guidelines Clin Infect Dis 32 2001 851 854